OncoTargets and Therapy

About OncoTargets and Therapy

About OncoTargets and Therapy

OncoTargets and Therapy is a peer-reviewed scholarly journal published by 2730 (New Zealand). It focuses on Q2. Publication coverage spans 2009-2026.

Key indicators: ISSN 1178-6930; H-index 100.

Understanding This Journal's Metrics

Journal metrics help researchers assess fit, but they must be interpreted in context:

• H-index (100): Exceptionally high — 100 articles have each been cited at least 100 times. This indicates deep, sustained influence in the field.

Publishing in OncoTargets and Therapy

An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.

• Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
• Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.

Is This Journal Right for Your Paper?

• Audience match: Will the journal's readers cite and build on your findings?
• Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
• Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
• Open access needs: Check funder mandates and whether the journal offers compliant OA options.

Frequently Asked Questions

What is the ISSN of OncoTargets and Therapy?
1178-6930.

Who publishes OncoTargets and Therapy?
2730.

What are OncoTargets and Therapy's metrics?
H-index 100.

Is OncoTargets and Therapy peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.